TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

K-V Pharmaceutical Company Under Investor Investigation Over Possible Securities Laws Violations

  • If you purchased shares of K-V Pharmaceutical Company (Public, NYSE:KV.A), and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

An investigation on behalf of investors of K-V Pharmaceutical Company (NYSE:KV.A) over possible violations of Federal Securities Laws in connection with Makena was announced. The investigation by a law firm focuses on certain statements made in connection with Makena. Makena is a drug treatment indicated to reduce the risk of preterm birth in women with a singleton pregnancy who hav...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: